SUBSCRIBE
SUBSCRIBE
BioCapital

Lapatinib Overcomes Tumor Resistance to Trastuzumab, University of California, Los Angeles (UCLA) Study Presented at American Association for Cancer Research Meeting

April 20, 2010 | 
1 min read

MedPage Today -- WASHINGTON -- Researchers suggested here that treatment with lapatinib (Tykerb) might be effective against breast cancer that has developed resistance to trastuzumab (Herceptin).

MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: FDA sign at its office in Washington, DC/iStock, JHVEPhoto
Policy
FDA Again Rejects Supernus Drug-Device Combo for Parkinson’s Disease
April 8, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: 3d illustration of hepatitis B viruses i
Drug Development
Altimmune Axes Hepatitis B Program After Phase II Failure, Focuses on Obesity and MASH
March 28, 2024
 · 
1 min read
 · 
Tyler Patchen